S. Wolfarth

1.3k total citations
49 papers, 1.1k citations indexed

About

S. Wolfarth is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, S. Wolfarth has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 24 papers in Neurology and 9 papers in Molecular Biology. Recurrent topics in S. Wolfarth's work include Neuroscience and Neuropharmacology Research (24 papers), Neurological disorders and treatments (17 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). S. Wolfarth is often cited by papers focused on Neuroscience and Neuropharmacology Research (24 papers), Neurological disorders and treatments (17 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). S. Wolfarth collaborates with scholars based in Poland, Germany and Czechia. S. Wolfarth's co-authors include Krystyna Ossowska, Jolanta Konieczny, Andrzej Pilc, Elżbieta Lorenc‐Koci, Jadwiga Wardas, M. Pietraszek, Joanna M. Wierońska, K.‐H. Sontag, G. Schulze and Maria Śmiałowska and has published in prestigious journals such as Brain Research, Neuroscience and Cellular and Molecular Life Sciences.

In The Last Decade

S. Wolfarth

48 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Wolfarth Poland 20 830 425 337 122 104 49 1.1k
Barbara L. Waszczak United States 23 888 1.1× 215 0.5× 565 1.7× 169 1.4× 93 0.9× 39 1.4k
Lisa Won United States 17 954 1.1× 412 1.0× 678 2.0× 72 0.6× 84 0.8× 39 1.3k
Jolanta Konieczny Poland 20 655 0.8× 449 1.1× 346 1.0× 50 0.4× 102 1.0× 47 975
Grégory Porras France 20 1.1k 1.4× 718 1.7× 514 1.5× 177 1.5× 140 1.3× 33 1.6k
Roberto Maj Italy 13 973 1.2× 473 1.1× 396 1.2× 301 2.5× 104 1.0× 33 1.4k
C. David Marsden United Kingdom 9 385 0.5× 448 1.1× 323 1.0× 71 0.6× 124 1.2× 11 920
Gaynor A. Larson United States 18 1.1k 1.4× 161 0.4× 737 2.2× 153 1.3× 81 0.8× 20 1.5k
Xiomara A. Perez United States 24 801 1.0× 477 1.1× 776 2.3× 109 0.9× 108 1.0× 31 1.4k
Ke‐Zhong Shen United States 18 1.0k 1.3× 491 1.2× 599 1.8× 187 1.5× 92 0.9× 29 1.3k
Yunmin Ding United States 13 655 0.8× 561 1.3× 369 1.1× 105 0.9× 84 0.8× 20 1.0k

Countries citing papers authored by S. Wolfarth

Since Specialization
Citations

This map shows the geographic impact of S. Wolfarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Wolfarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Wolfarth more than expected).

Fields of papers citing papers by S. Wolfarth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Wolfarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Wolfarth. The network helps show where S. Wolfarth may publish in the future.

Co-authorship network of co-authors of S. Wolfarth

This figure shows the co-authorship network connecting the top 25 collaborators of S. Wolfarth. A scholar is included among the top collaborators of S. Wolfarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Wolfarth. S. Wolfarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ossowska, Krystyna, Jolanta Konieczny, Jadwiga Wardas, et al.. (2006). An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats. Amino Acids. 32(2). 179–188. 45 indexed citations
2.
Ossowska, Krystyna, Jolanta Konieczny, S. Wolfarth, & Andrzej Pilc. (2005). MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats. Neuropharmacology. 49(4). 447–455. 42 indexed citations
3.
Ossowska, Krystyna, Jadwiga Wardas, Maria Śmiałowska, et al.. (2005). A slowly developing dysfunction of dopaminergic nigrostriatal neurons induced by long‐term paraquat administration in rats: an animal model of preclinical stages of Parkinson's disease?. European Journal of Neuroscience. 22(6). 1294–1304. 103 indexed citations
4.
Lorenc‐Koci, Elżbieta, Jadwiga Wardas, Gerd D. Bartoszyk, & S. Wolfarth. (2003). Contribution of the serotonin 5-HT1A receptor agonism of 8-OH-DPAT and EMD 128130 to the regulation of haloperidol-induced muscle rigidity in rats. Neuropharmacology. 45(8). 1057–1069. 9 indexed citations
5.
Wardas, Jadwiga, M. Pietraszek, S. Wolfarth, & Krystyna Ossowska. (2003). The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson′s disease. Neuroscience. 122(3). 747–756. 18 indexed citations
6.
Gołembiowska, Krystyna, Jolanta Konieczny, Krystyna Ossowska, & S. Wolfarth. (2002). The role of striatal metabotropic glutamate receptors in degeneration of dopamine neurons: Review article. Amino Acids. 23(1-3). 199–205. 18 indexed citations
7.
Ossowska, Krystyna, M. Pietraszek, Jadwiga Wardas, et al.. (2000). The role of glutamate receptors in antipsychotic drug action. Amino Acids. 19(1). 87–94. 35 indexed citations
8.
9.
Konieczny, Jolanta, Krystyna Ossowska, S. Wolfarth, & Andrzej Pilc. (1998). LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(4). 500–502. 74 indexed citations
10.
Ossowska, Krystyna, Elżbieta Lorenc‐Koci, Jolanta Konieczny, & S. Wolfarth. (1998). The role of striatal glutamate receptors in models of Parkinson's disease. Amino Acids. 14(1-3). 11–15. 15 indexed citations
11.
Wolfarth, S., Elżbieta Lorenc‐Koci, G. Schulze, et al.. (1997). Age-related muscle stiffness: predominance of non-reflex factors. Neuroscience. 79(2). 617–628. 15 indexed citations
12.
Wolfarth, S., Jolanta Konieczny, Maria Śmiałowska, G. Schulze, & Krystyna Ossowska. (1996). Influence of 6-hydroxydopamine lesion of the dopaminergic nigrostriatal pathway on the muscle tone and electromyographic activity measured during passive movements. Neuroscience. 74(4). 985–996. 32 indexed citations
13.
Ossowska, Krystyna, Elżbieta Lorenc‐Koci, G. Schulze, & S. Wolfarth. (1996). The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats. Neuroscience Letters. 203(2). 73–76. 18 indexed citations
14.
Lorenc‐Koci, Elżbieta, S. Wolfarth, & Krystyna Ossowska. (1996). Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity. Experimental Brain Research. 109(2). 268–76. 68 indexed citations
15.
Lorenc‐Koci, Elżbieta, Krystyna Ossowska, Jadwiga Wardas, & S. Wolfarth. (1995). Does reserpine induce parkinsonian rigidity?. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 9(2-3). 211–223. 30 indexed citations
16.
Ossowska, Krystyna, Elżbieta Lorenc‐Koci, & S. Wolfarth. (1994). Antiparkinsonian action of MK-801 on the reserpine-induced rigidity: A mechanomyographic analysis. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 7(2). 143–152. 25 indexed citations
17.
Ossowska, Krystyna & S. Wolfarth. (1994). Contralateral rotations induced by intrastriatal injections of agonists of excitatory amino acid receptors.. PubMed. 46(1-2). 71–4. 4 indexed citations
18.
Wolfarth, S., et al.. (1992). MUSCLE WEAKNESS AND CONTINUOUS EMG ACTIVITY IN SENILE RATS; AN ANIMAL MODEL OF SPASTICITY?. Behavioural Pharmacology. 3(Supplement). 81–81. 2 indexed citations
19.
Kolasiewicz, Wacław, A.R. Cools, Krystyna Ossowska, & S. Wolfarth. (1987). The neostriatal inhibition of catalepsy, but not of muscle rigidity, evoked from the substantia nigra pars reticulata. Pharmacology Biochemistry and Behavior. 28(4). 453–457. 7 indexed citations
20.
Wolfarth, S., et al.. (1977). The participation of the nigro-thalamic pathway in the nigral control of the caudate nucleus.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 29(1). 49–60. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara L. Waszczak Breakdown of academic impact, for papers by Lisa Won Breakdown of academic impact, for papers by Jolanta Konieczny Breakdown of academic impact, for papers by Grégory Porras Breakdown of academic impact, for papers by Roberto Maj Breakdown of academic impact, for papers by C. David Marsden Breakdown of academic impact, for papers by Gaynor A. Larson Breakdown of academic impact, for papers by Xiomara A. Perez Breakdown of academic impact, for papers by Ke‐Zhong Shen Breakdown of academic impact, for papers by Yunmin Ding
Rankless by CCL
2026